Dihydromyricetin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dihydromyricetin, covering 2024-09-03 to 2024-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease [Phase 1]